Literature DB >> 35499795

The Role of TDP-43 in Neurodegenerative Disease.

Yan-Zhe Liao1, Jing Ma2, Jie-Zhi Dou3.   

Abstract

In recent years, more and more neurodegenerative diseases, such as ALS, FTLD and AD, have been found to share a common pathological feature, which is the depletion of TDP-43 in the nucleus and the accumulation of TDP-43 in the cytoplasm through hyperphosphorylation, ubiquitination and cleavage. Therefore, this kind of neurodegenerative disease is also called TDP-43 proteinopathy. This suggests that TDP-43 plays a role in the pathogenesis of disease. Current studies show that the pathophysiological mechanism of TDP-43 in neurodegeneration is very complex. In this review, we describe the structure of TDP-43, its main physiological functions, the possible pathogenesis and how TDP-43 provides a new pathway to treat neurodegenerative diseases.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neurodegenerative disease; TDP-43; TDP-43 proteinopathy

Mesh:

Substances:

Year:  2022        PMID: 35499795     DOI: 10.1007/s12035-022-02847-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  142 in total

Review 1.  Cytoplasmic functions of TDP-43 and FUS and their role in ALS.

Authors:  Nicol Birsa; Matthew Peter Bentham; Pietro Fratta
Journal:  Semin Cell Dev Biol       Date:  2019-06-04       Impact factor: 7.727

2.  TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling.

Authors:  Tao Zhang; Patrick C Mullane; Goran Periz; Jiou Wang
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

Review 3.  TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis.

Authors:  Valle Palomo; Carlota Tosat-Bitrian; Vanesa Nozal; Siranjeevi Nagaraj; Angeles Martin-Requero; Ana Martinez
Journal:  ACS Chem Neurosci       Date:  2019-03-04       Impact factor: 4.418

Review 4.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.

Authors:  Emma L Scotter; Han-Jou Chen; Christopher E Shaw
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects.

Authors:  Jer-Cherng Chang; David B Morton
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

Authors:  Ching-Chieh Chou; Yi Zhang; Mfon E Umoh; Spencer W Vaughan; Ileana Lorenzini; Feilin Liu; Melissa Sayegh; Paul G Donlin-Asp; Yu Han Chen; Duc M Duong; Nicholas T Seyfried; Maureen A Powers; Thomas Kukar; Chadwick M Hales; Marla Gearing; Nigel J Cairns; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers; Yong-Jie Zhang; Leonard Petrucelli; Rita Sattler; Daniela C Zarnescu; Jonathan D Glass; Wilfried Rossoll
Journal:  Nat Neurosci       Date:  2018-01-08       Impact factor: 24.884

8.  TDP-43 Is Elevated in Plasma Neuronal-Derived Exosomes of Patients With Alzheimer's Disease.

Authors:  Nan Zhang; Dongmei Gu; Meng Meng; Marc L Gordon
Journal:  Front Aging Neurosci       Date:  2020-06-04       Impact factor: 5.750

Review 9.  A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease.

Authors:  Jayden A Clark; Elise J Yeaman; Catherine A Blizzard; Jyoti A Chuckowree; Tracey C Dickson
Journal:  Front Cell Neurosci       Date:  2016-09-13       Impact factor: 5.505

10.  Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes.

Authors:  James N Sleigh; Andrew P Tosolini; David Gordon; Anny Devoy; Pietro Fratta; Elizabeth M C Fisher; Kevin Talbot; Giampietro Schiavo
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

View more
  2 in total

1.  Microbiome and Neurotrauma: Emerging Innovations.

Authors:  A Clark; R Zelmanovich; M R Hosseini Siyanaki; M Michel; C Hanna; C Davidson; B Lucke-Wold
Journal:  Neurol Neurother Open Access J       Date:  2022-08-16

Review 2.  Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.

Authors:  Jolien Perneel; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2022-09-02       Impact factor: 15.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.